This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Cutaneous Adverse Effect Due to Prophylactic Antiviral Therapy With Protease Inhibitor

C. Aquilina, MD; R. Viraben, MD; A. Roueire, MD

Arch Intern Med. 1998;158:2160-2161.

We describe a human immunodeficiency virus–seronegative man who presented with a skin disorder that we diagnosed as acute generalized exanthematous pustulosis, which we believe was an adverse reaction to combination prophylactic therapy with zidovudine, lamivudine, and protease inhibitor for human immunodeficiency virus. Cutaneous adverse effects are rarely reported with the use of these antiviral drugs.

From the Service de Dermatovénéréologie (Drs Aquilina and Viraben) and the Centre des Maladies Venériennes (Dr Roueire), Hôpital La Grave, Toulouse, France.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?